3637

    530019

    JUBLPHARMA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    JUBILANT PHARMOVA LTD Share Price Today

    JUBILANT PHARMOVA LTD is currently trading at ₹979.7, up by ₹14.35 from the previous close. The stock touched an intraday high of ₹988.75 and a low of ₹972.50 during the latest trading session. Over the past one year, JUBILANT PHARMOVA LTD has delivered a loss of 17.84%, while the stock has declined 0.76% in the last one month.

    JUBILANT PHARMOVA LTD performance

    Today’s low Today’s high
    ₹ 972.50 ₹ 988.75
    ₹ 979.70
    52 week low 52 week high
    ₹ 786.05 ₹ 1248.00
    ₹ 979.70
    Open Price ₹ 975.00
    Prev. Close ₹ 965.35
    Volume (Shares) 117876.00
    Total traded value ₹ 1154.83
    Upper Circuit ₹ 1158.40
    Lower Circuit ₹ 772.30
    info

    Investment Returns

    Over 1 Month -0.76% Over 3 Months 2.11% Over 6 Months 2.81% Over 1 Year -17.84%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    JUBILANT PHARMOVA LTD fundamentals


    • Market cap (Cr) 15,606.60
    • P/E Ratio (TTM) 242.32
    • Beta 0.70
    • Book Value / share 145.15
    • Return on equity 1.04%
    • EPS (TTM) 1.97
    • Dividend yield 0.52%
    • Net profit/quarter (Cr) 57.20
    info icon alternate text
    • Market cap (Cr) 15,583.50
    • P/E Ratio (TTM) 242.32
    • Beta 0.68
    • Book Value / share 145.15
    • Return on equity 1.04%
    • EPS (TTM) 1.97
    • Dividend yield 0.52%
    • Net profit/quarter (Cr) 57.20
    info icon alternate text

    JUBILANT PHARMOVA LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 70.30
    Operating Expense 58.00
    Net Profit 57.20
    Net Profit Margin (%) 81.36
    Earnings Per Share (EPS) 3.59
    EBITDA 6.30
    Effective Tax Rate (%) -1295.12
    Particulars DEC 2025 (Values in Cr)
    Revenue 67.30
    Operating Expense 57.60
    Net Profit 6.60
    Net Profit Margin (%) 9.80
    Earnings Per Share (EPS) 0.42
    EBITDA 12.60
    Effective Tax Rate (%) 34.65
    Particulars SEP 2025 (Values in Cr)
    Revenue 66.30
    Operating Expense 58.70
    Net Profit -6.40
    Net Profit Margin (%) -9.65
    Earnings Per Share (EPS) -0.40
    EBITDA 12.60
    Effective Tax Rate (%) 664.70
    Particulars JUN 2025 (Values in Cr)
    Revenue 59.50
    Operating Expense 53.70
    Net Profit 5.80
    Net Profit Margin (%) 9.74
    Earnings Per Share (EPS) 0.36
    EBITDA 11.00
    Effective Tax Rate (%) 36.92
    Particulars MAR 2025 (Values in Cr)
    Revenue 60.50
    Operating Expense 54.40
    Net Profit 13.60
    Net Profit Margin (%) 22.47
    Earnings Per Share (EPS) 0.86
    EBITDA 11.20
    Effective Tax Rate (%) 86.36
    Particulars MAR 2026 (Values in Cr)
    Revenue 263.40
    Operating Expense 228.00
    Net Profit 63.20
    Net Profit Margin (%) 23.99
    Earnings Per Share (EPS) 3.97
    EBITDA 42.50
    Effective Tax Rate (%) 31.84
    Particulars MAR 2025 (Values in Cr)
    Revenue 231.20
    Operating Expense 210.20
    Net Profit 19.20
    Net Profit Margin (%) 8.30
    Earnings Per Share (EPS) 1.21
    EBITDA 60.90
    Effective Tax Rate (%) 46.37
    Particulars MAR 2024 (Values in Cr)
    Revenue 755.20
    Operating Expense 846.40
    Net Profit 31.60
    Net Profit Margin (%) 4.18
    Earnings Per Share (EPS) 1.99
    EBITDA 119.89
    Effective Tax Rate (%) 24.22
    Particulars MAR 2023 (Values in Cr)
    Revenue 774.40
    Operating Expense 868.70
    Net Profit 49.90
    Net Profit Margin (%) 6.44
    Earnings Per Share (EPS) 3.13
    EBITDA 141.00
    Effective Tax Rate (%) 37.07
    Particulars MAR 2022 (Values in Cr)
    Revenue 701.14
    Operating Expense 767.17
    Net Profit 80.49
    Net Profit Margin (%) 11.47
    Earnings Per Share (EPS) 5.05
    EBITDA 132.62
    Effective Tax Rate (%) 4.99
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 395.88
    ROE % 9.50
    ROCE % 8.39
    Total Debt to Total Equity 0.55
    EBITDA Margin 17.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 343.92
    ROE % 0.76
    ROCE % 6.37
    Total Debt to Total Equity 0.68
    EBITDA Margin 14.82
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 339.58
    ROE % -7.33
    ROCE % 3.05
    Total Debt to Total Equity 0.64
    EBITDA Margin 13.21
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 334.10
    ROE % 8.21
    ROCE % 9.52
    Total Debt to Total Equity 0.60
    EBITDA Margin 18.88
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 297.85
    ROE % 16.55
    ROCE % 11.86
    Total Debt to Total Equity 0.74
    EBITDA Margin 23.48
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 145.79
    ROE % 1.04
    ROCE % 2.88
    Total Debt to Total Equity 0.15
    EBITDA Margin 17.66
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 149.34
    ROE % 1.32
    ROCE % 2.57
    Total Debt to Total Equity 0.15
    EBITDA Margin 15.28
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 151.86
    ROE % 2.06
    ROCE % 3.60
    Total Debt to Total Equity 0.11
    EBITDA Margin 17.41
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 153.11
    ROE % 4.33
    ROCE % 4.31
    Total Debt to Total Equity 0.18
    EBITDA Margin 18.27
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 80.51
    ROE % 11.03
    ROCE % 11.58
    Total Debt to Total Equity 0.65
    EBITDA Margin 17.53
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1088.80
    Total Assets 12756.40
    Total Liabilities 12756.40
    Total Equity 6238.60
    Share Outstanding 15
    Price to Book Ratio 6.12
    Return on Assets (%) 6.58
    Return on Capital (%) 9.68
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 956.80
    Total Assets 11548.50
    Total Liabilities 11548.50
    Total Equity 5421.10
    Share Outstanding 15
    Price to Book Ratio 3.81
    Return on Assets (%) 0.66
    Return on Capital (%) 0.87
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1014.30
    Total Assets 11156.70
    Total Liabilities 11156.70
    Total Equity 5391.80
    Share Outstanding 15
    Price to Book Ratio 1.84
    Return on Assets (%) -0.54
    Return on Capital (%) -0.69
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 984.23
    Total Assets 9990.86
    Total Liabilities 9990.86
    Total Equity 5316.40
    Share Outstanding 15
    Price to Book Ratio 2.53
    Return on Assets (%) 4.14
    Return on Capital (%) 5.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 671.31
    Total Assets 8918.11
    Total Liabilities 8918.11
    Total Equity 4741.51
    Share Outstanding 15
    Price to Book Ratio 8.45
    Return on Assets (%) 9.37
    Return on Capital (%) 11.41
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 12.60
    Total Assets 2909.60
    Total Liabilities 2909.60
    Total Equity 2318.10
    Share Outstanding 15
    Price to Book Ratio 6.12
    Return on Assets (%) 0.65
    Return on Capital (%) 0.73
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 36.10
    Total Assets 2991.90
    Total Liabilities 2991.90
    Total Equity 2374.50
    Share Outstanding 15
    Price to Book Ratio 3.81
    Return on Assets (%) 1.05
    Return on Capital (%) 1.16
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 11.00
    Total Assets 3008.40
    Total Liabilities 3008.40
    Total Equity 2414.50
    Share Outstanding 15
    Price to Book Ratio 1.84
    Return on Assets (%) 1.65
    Return on Capital (%) 1.84
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 22.52
    Total Assets 2895.55
    Total Liabilities 2895.55
    Total Equity 2439.06
    Share Outstanding 15
    Price to Book Ratio 2.53
    Return on Assets (%) 2.77
    Return on Capital (%) 3.08
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 40.32
    Total Assets 1844.59
    Total Liabilities 1844.59
    Total Equity 1282.44
    Share Outstanding 15
    Price to Book Ratio 8.45
    Return on Assets (%) 11.62
    Return on Capital (%) 12.08
    Particulars MAR 2025 (Values in Cr)
    Net Income 980.60
    Cash from Operations 1310.50
    Cash from Investing 487.70
    Cash from Financing -1452.70
    Net change in Cash 131.90
    Free Cash Flow 2426.10
    Particulars MAR 2024 (Values in Cr)
    Net Income 170.50
    Cash from Operations 1179.00
    Cash from Investing -607.90
    Cash from Financing -432.50
    Net change in Cash -57.50
    Free Cash Flow 2076.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 27.80
    Cash from Operations 865.00
    Cash from Investing -544.40
    Cash from Financing -156.70
    Net change in Cash 30.10
    Free Cash Flow 1679.50
    Particulars MAR 2022 (Values in Cr)
    Net Income 630.44
    Cash from Operations 1031.63
    Cash from Investing -380.37
    Cash from Financing -32.59
    Net change in Cash 481.86
    Free Cash Flow 1631.62
    Particulars MAR 2021 (Values in Cr)
    Net Income 1212.01
    Cash from Operations 2178.38
    Cash from Investing -739.01
    Cash from Financing -1709.38
    Net change in Cash -651.87
    Free Cash Flow 2705.87
    Particulars MAR 2025 (Values in Cr)
    Net Income 37.60
    Cash from Operations 148.10
    Cash from Investing -2.30
    Cash from Financing -156.80
    Net change in Cash -23.50
    Free Cash Flow 169.50
    Particulars MAR 2024 (Values in Cr)
    Net Income 41.70
    Cash from Operations 155.40
    Cash from Investing -40.30
    Cash from Financing -77.80
    Net change in Cash 25.10
    Free Cash Flow 223.00
    Particulars MAR 2023 (Values in Cr)
    Net Income 79.30
    Cash from Operations -47.70
    Cash from Investing 31.10
    Cash from Financing 22.50
    Net change in Cash -11.50
    Free Cash Flow 11.89
    Particulars MAR 2022 (Values in Cr)
    Net Income 84.72
    Cash from Operations 32.61
    Cash from Investing 93.10
    Cash from Financing -107.37
    Net change in Cash -17.82
    Free Cash Flow 70.00
    Particulars MAR 2021 (Values in Cr)
    Net Income 273.16
    Cash from Operations 650.97
    Cash from Investing 177.95
    Cash from Financing -781.64
    Net change in Cash 4.68
    Free Cash Flow 743.77
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 13.46 1.57 248.68 23.12 38.85
    BLISS GVS PHARMA LTD 463.55 37.26 4.12 4916.24 118.35 552.90
    CIPLA LTD. 1410.90 31.85 3.31 113978.90 1165.55 1672.20
    FERMENTA BIOTECH LTD. 432.60 20.23 3.13 1273.18 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 22.69 4.18 248.68 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 510.50 22.88 3.98 1475.89 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8000.10 104.55 22.91 20000.25 7630.00 9850.00
    BLISS GVS PHARMA LTD 463.55 50.11 4.25 4916.24 118.35 552.90

    JUBILANT PHARMOVA LTD shareholding pattern

    Holding
    24.05%
    47.67%
    15.87%
    12.39%
    6.58%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    JUBILANT PHARMOVA LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    979.70 1.48 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 983.90
    • 26 Days 984.60
    • 10 Days 989.00
    • 50 Days 975.60
    • 12 Days 988.90
    • 100 Days 969.80
    • 20 Days 986.60
    • 200 Days 985.30
    962.35 PIVOT
    First Support 953.60 First Resistance 974.10 Second Support 941.85 Second Resistance 982.85 Third Support 933.10 Third Resistance 994.60
    RSI 43.39 ADX 21.43 MACD 4.33 Williams % R -83.86 Commodity Channel Index (CCI) -87.36
    Date 2026-07-24 Week 38500.00 Same Day 24493.00 Month 58371.00
    1 Year 0.70 3 Year 0.87
    Over 1 Month
    -0.76% down
    Over 1 Year
    -17.84% down
    Over 3 Months
    2.11% down
    Over 3 Years
    37.36% down
    Over 6 Months
    2.81% down
    Over 5 Years
    6.81% down

    JUBILANT PHARMOVA LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 5.0 Final 24 Jul 2026 Equity shares
    25 Jul 2025 5.0 Final 25 Jul 2025 Equity shares
    02 Aug 2024 5.0 Final 02 Aug 2024 Equity shares
    10 Aug 2023 5.0 Final 10 Aug 2023 Equity shares
    11 Aug 2022 5.0 Final 12 Aug 2022 Equity shares
    05 Aug 2021 5.0 Final 06 Aug 2021 Equity shares
    09 Mar 2020 5.0 Interim 11 Mar 2020 Equity shares
    12 Sep 2019 4.5 Final 14 Sep 2019 Equity shares
    12 Sep 2018 3.0 Final 15 Sep 2018 Equity shares
    16 Aug 2017 3.0 Final 19 Aug 2017 Equity shares
    18 Aug 2016 3.0 Final 20 Aug 2016 Equity shares
    20 Aug 2015 3.0 Final 22 Aug 2015 Equity shares
    21 Aug 2014 3.0 Final 23 Aug 2014 Equity shares
    14 Aug 2013 3.0 Final 17 Aug 2013 Equity shares
    14 Aug 2012 3.0 Final 17 Aug 2012 Equity shares
    10 Aug 2011 2.0 Final 12 Aug 2011 Equity shares
    17 Sep 2010 2.0 Final 21 Sep 2010 Equity shares
    29 Jun 2009 1.5 Final 01 Jul 2009 Equity shares
    17 Sep 2008 1.5 Final 19 Sep 2008 Equity shares
    17 Sep 2007 1.25 Final 19 Sep 2007 Equity shares
    08 Sep 2006 0.0 Final 12 Sep 2006 Equity shares
    Ex-Date Ex-Bonus Ratio
    15 Mar 2004 12 Mar 2004 3:5
    Ex-Date Old FV NEW FV Record Date
    17 Mar 2006 5.0 1.0 24 Mar 2006
    12 Nov 2002 10.0 5.0 21 Nov 2002
    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 5.0 Final 24 Jul 2026 Equity shares
    25 Jul 2025 5.0 Final 25 Jul 2025 Equity shares
    02 Aug 2024 5.0 Final 02 Aug 2024 Equity shares
    10 Aug 2023 5.0 Final 10 Aug 2023 Equity shares
    11 Aug 2022 5.0 Final 12 Aug 2022 Equity shares
    05 Aug 2021 5.0 Final 06 Aug 2021 Equity shares
    09 Mar 2020 5.0 Interim 11 Mar 2020 Equity shares
    12 Sep 2019 4.5 Final 14 Sep 2019 Equity shares
    12 Sep 2018 3.0 Final 15 Sep 2018 Equity shares
    16 Aug 2017 3.0 Final 19 Aug 2017 Equity shares
    18 Aug 2016 3.0 Final 20 Aug 2016 Equity shares
    20 Aug 2015 3.0 Final 22 Aug 2015 Equity shares
    21 Aug 2014 3.0 Final 23 Aug 2014 Equity shares
    14 Aug 2013 3.0 Final 17 Aug 2013 Equity shares
    14 Aug 2012 3.0 Final 17 Aug 2012 Equity shares
    10 Aug 2011 2.0 Final 12 Aug 2011 Equity shares
    17 Sep 2010 2.0 Final 21 Sep 2010 Equity shares
    29 Jun 2009 1.5 Final 01 Jul 2009 Equity shares
    17 Sep 2008 1.5 Final 19 Sep 2008 Equity shares
    17 Sep 2007 1.25 Final 19 Sep 2007 Equity shares
    08 Sep 2006 0.0 Final 12 Sep 2006 Equity shares
    Ex-Date Ex-Bonus Ratio
    15 Mar 2004 12 Mar 2004 3:5
    Ex-Date Old FV NEW FV Record Date
    17 Mar 2006 5.0 1.0 24 Mar 2006
    12 Nov 2002 10.0 5.0 21 Nov 2002

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Jubilant Pharmova Ltd?

    Answer Field

    Jubilant Pharmova Ltd share price is for NSE ₹ 979.70 & for BSE ₹ 975.00 as on Jul 27 2026 03:30 PM.

    What is the Market Cap of Jubilant Pharmova Ltd Share?

    Answer Field

    The market cap of Jubilant Pharmova Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 27 2026 03:30 PM.

    What is the 52 Week High and Low of Jubilant Pharmova Ltd?

    Answer Field

    The 52 Week High and Low of Jubilant Pharmova Ltd for NSE is ₹ 1,248.00 and ₹ 786.05 and for BSE is ₹ 1,250.00 and ₹ 783.75.

    What is 1 year return for Jubilant Pharmova Ltd?

    Answer Field

    The 1 year returns on the stock has been -17.84%.

    What is the P/E Ratio of Jubilant Pharmova Ltd Share?

    Answer Field

    As on Jul 27 2026 03:30 PM the price-to-earnings (PE) ratio for Jubilant Pharmova Ltd share is 242.32.

    What is the PB ratio of Jubilant Pharmova Ltd Share?

    Answer Field

    As on Jul 27 2026 03:30 PM, the price-to-book (PB) ratio for Jubilant Pharmova Ltd share is 145.15.

    How to Buy Jubilant Pharmova Ltd Share?

    Answer Field

    You can trade in Jubilant Pharmova Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Jubilant Pharmova Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Jubilant Pharmova Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Jubilant Pharmova Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |